Swallow Solutions, LLC, a Madison, WI-based life sciences company with a novel dysphagia treatment platform, raised $1.046m in Series A financing.
The round was led by Venture Management, LLC, with participation from NEW Capital Fund, LP, Wisconsin Investment Partners, and individual investors.
Led by Dr. Bob Carlson (CEO) and Dr. JoAnne Robbins (Chief Clinical/Scientific Officer), Swallow Solutions focuses on two areas related to dysphagia – therapeutic devices for diagnosing and treating swallowing disorders and nutritional food products tailored to the patient’s diagnosed level of swallowing difficulty.
The company intends to use the capital to commercialize a portfolio of innovative dysphagia treatment products and to add new products and services developed by Dr. Robbins and her team at the University of Wisconsin.
Early trials indicate that many patients using Swallow Solutions can, and do, regain all or a significant portion of their ability to swallow effectively.